Eiji Kobayashi is based in the department of otolaryngology, specifically head and neck surgery. He graduated from the graduate school of Kanazawa University in 2018 and received his Ph.D. degree. He has worked on the mechanism of exosome biogenesis through UCH-L1 in the context of nasopharyngeal carcinoma, and the application of UCH-L1 inhibitor to clinics. Currently, his work is focused on exosome biogenesis and protein loading mechanism through farnesylation.